Steve Scala
Stock Analyst at TD Cowen
(4.41)
# 1,215
Out of 4,649 analysts
395
Total ratings
62.3%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Initiated Coverage: Buy | n/a | $26.79 | - | 44 | Aug 11, 2026 | |
| GSK GSK plc | Maintained: Hold | $70 | $49.52 | +41.36% | 30 | Aug 3, 2026 | |
| ABBV AbbVie | Maintained: Buy | $280 | $249.46 | +12.24% | 40 | Jul 31, 2026 | |
| NVS Novartis AG | Maintained: Hold | $180 | $150.88 | +19.30% | 35 | Jul 27, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $300 | $260.35 | +15.23% | 1 | Jul 13, 2026 | |
| ZTS Zoetis | Rated: Buy | $150 → $104 | $73.79 | +40.94% | 24 | Jun 30, 2026 | |
| SNY Sanofi | Maintained: Hold | $57 | $43.72 | +30.38% | 25 | Jun 29, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $24 → $32 | $23.67 | +35.19% | 17 | Jun 18, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | n/a | $11,460.00 | - | 8 | Apr 30, 2026 | |
| RHHBY Roche Holding AG | Maintained: Hold | $67 | $54.52 | +22.89% | 27 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,250 | $1,180.16 | +5.92% | 47 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $120 → $137 | $135.84 | +0.85% | 31 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $8.05 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $54 | $63.83 | n/a | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $15 | $13.72 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16.65 | $9.02 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $58.60 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.23 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.99 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 96.59 → CHF 109.47 | CHF 122.44 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $45.89 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,054 | kr 294.70 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,250p → 1,790p | 1,818p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 355.10 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €41.50 → €98.00 | €75.52 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.67 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €67.43 → €74.35 | €136.30 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $415.21 | n/a | 2 | Oct 3, 2017 |
Pfizer
Aug 11, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.79
Upside: -
GSK plc
Aug 3, 2026
Maintained: Hold
Price Target: $70
Current: $49.52
Upside: +41.36%
AbbVie
Jul 31, 2026
Maintained: Buy
Price Target: $280
Current: $249.46
Upside: +12.24%
Novartis AG
Jul 27, 2026
Maintained: Hold
Price Target: $180
Current: $150.88
Upside: +19.30%
Johnson & Johnson
Jul 13, 2026
Maintained: Buy
Price Target: $300
Current: $260.35
Upside: +15.23%
Zoetis
Jun 30, 2026
Rated: Buy
Price Target: $150 → $104
Current: $73.79
Upside: +40.94%
Sanofi
Jun 29, 2026
Maintained: Hold
Price Target: $57
Current: $43.72
Upside: +30.38%
Elanco Animal Health
Jun 18, 2026
Rated: Buy
Price Target: $24 → $32
Current: $23.67
Upside: +35.19%
AstraZeneca PLC
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $11,460.00
Upside: -
Roche Holding AG
Apr 23, 2026
Maintained: Hold
Price Target: $67
Current: $54.52
Upside: +22.89%
Apr 2, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,180.16
Upside: +5.92%
Mar 30, 2026
Maintained: Hold
Price Target: $120 → $137
Current: $135.84
Upside: +0.85%
Aug 7, 2025
Maintained: Hold
Price Target: $9 → $8
Current: $8.05
Upside: n/a
Jul 31, 2025
Maintained: Hold
Price Target: $64 → $54
Current: $63.83
Upside: n/a
Apr 22, 2025
Maintained: Hold
Price Target: $19 → $15
Current: $13.72
Upside: n/a
Feb 21, 2025
Maintained: Hold
Price Target: $16.65
Current: $9.02
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $58.60
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.23
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $5.99
Upside: n/a
Nov 11, 2024
Maintained: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 122.44
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $45.89
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: kr 1,054
Current: kr 294.70
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: 2,250p → 1,790p
Current: 1,818p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 355.10
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €41.50 → €98.00
Current: €75.52
Upside: n/a
Jun 24, 2021
Maintained: Buy
Price Target: n/a
Current: $4.67
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €67.43 → €74.35
Current: €136.30
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $415.21
Upside: n/a